High SATB1 expression was also found to correlate with increased FIGO stage, lymph node metastasis and reduced overall survival, but it was not reported whether SATB1 was an independent prognostic factor[10]. This evidence concerns the gene SATB1 and metastatic malignant neoplasm in the lymph nodes.